Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000041568Phase 4Recruiting
Phase 4, randomised trial in procedural discomfort comparing Remimazolam group with Propofol group (2 arms). Primary endpoints: Postoperative quality of recovery scale (primary), Incidence of adverse events (hypotension, respiratory depression, pain at injection site) and 4 more. Started Feb 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000041568.